The Importance of the Induction of Gene Expression and Differentiation by Cytotoxic Chemotherapy

References

• Waxman S, Scher W, Scher B M. Basic principles for utilizing combination differentiation agents. Cancer Detect Prev 1986; 9: 395–407
   PubMedGoogle Scholar
• Reiss M, Gamba-Vitalo C, Sartorelli A C. Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms. Cancer Treat Rep 1986; 70: 201–218
   PubMedGoogle Scholar
• Freshney R I. Induction of differentiation in neoplastic cells. Anticancer Res 1985; 5: 111–130
   PubMed Web of Science ®Google Scholar
• Sartorelli A C. Malignant cell differentiation as a potential therapeutic aproach. Br J Cancer 1985; 32: 293–302
   Google Scholar
• Chesson B D, Jasperse D M, Chun H G, et al. Differentiating agents in the treatment of human malignancies. Cancer Treat Rep 1986; 13: 129–145
   Google Scholar
• Fearon E R, Burke P J, Schiffer C A, et al. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med 1986; 315: 15–24
   PubMed Web of Science ®Google Scholar
• Housset M, Degos D MT, Degos L. Small doses of ara-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemic cells. Br J Haematol 1982; 51: 125–129
   PubMed Web of Science ®Google Scholar
• Wisch J S, Griffin J D, Kufe D W. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. N Engl I Med 1983; 309: 1652–1653
   Google Scholar
• Gateff E. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 1978; 200: 1448–1459
   PubMedGoogle Scholar
• Nowell P C. Mechanisms of tumor progression. Cancer Res 1986; 46: 2203–2207
   PubMed Web of Science ®Google Scholar
• Bell D R, Geriach J H, Kanner N, et al. Detection of P-glycoprotein in ovarian cancer; a molecular marker associated with multidrug resistance. J Clin Oncol 1985; 3: 311–315
   PubMed Web of Science ®Google Scholar
• Hong W K, Wittes R E, Hajdu S T, et al. The evolution of mature teratoma from malignant tumours. Cancer 1977; 40: 2987–2989
   PubMed Web of Science ®Google Scholar
• Speers W C. Conversion of malignant murine embryonal carcinomas to benign teratomas by chemical induction of differentiation in vivo. Cancer Res 1982; 42: 1843–1849
   PubMed Web of Science ®Google Scholar
• Schwartz E L, Ishiguro K, Sartorelli A C. Induction of leukemia cell differentiation by chemotherapeutic agents. Adv Enz Reg 1983; 21: 3–20
   PubMedGoogle Scholar
• Kasukabe T, Honma Y, Hozumi M, et al. Control of proliferating potential of myeloid leukemia cells during long-term treatment with Vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies. Cancer Res 1987; 47: 567–572
   PubMed Web of Science ®Google Scholar
• Ishiguro K, Schwartz E L, Sartorelli A C. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells. J Cell Physiol 1984; 121: 383–390
   PubMed Web of Science ®Google Scholar
• Schwartz E L, Sartorelli A C. Structure activity relationships for the induction of differentiation of HL 60 human acute leukemia cells by anthracyclines. Cancer Res 1982; 42: 2651–2655
   PubMed Web of Science ®Google Scholar
• Slamon D J, Clark G M, Wong S G, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182
   PubMed Web of Science ®Google Scholar
• Preisler H D, Kinniburgh A J, Wei-Dong G, et al. Expression of the protooncogenes c-myc, c-fos and c-fins in acute myelocytic leukemia at diagnosis and in remission. Cancer Res 1987; 47: 874–880
   PubMed Web of Science ®Google Scholar
• Humphries R K, Dover G, Young N S, et al. 5-azacytidine acts directly on both erythroid precursor and progenitors to increase production of fetal hemoglobin. J Clin Invest 1985; 75: 547–557
   PubMed Web of Science ®Google Scholar
• Flynn P J, Miller W J, Weisdorf D J, et al. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood 1983; 62: 1211–1217
   PubMed Web of Science ®Google Scholar
• Sigaux F, Castaigne S, Lehn F, et al. Alpha JFN in hairy cell leukemia: differentiation or cytotoxicity?. First Conference on Differentiation Therapy, Villasimius, Sardinia, 1986; 76
   Google Scholar
• Roller C A, Miller D M. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med 1986; 315: 1433–1437
   PubMed Web of Science ®Google Scholar
• Roller C A, Campbell V W, Polansky D A, et al. In vivo differentiation of blast-phase chronic granulocytic leukemia: expression of c-myc and c-abl protooncogenes. J Clin Invest 1985; 76: 365–369
   PubMed Web of Science ®Google Scholar
• Waxman S. Prospective for leukemia research and therapy. The Leukemia Cell, A D Rubin, S Waxman. CRC Press, Boca Raton, FL 1979; 169–175
   Google Scholar
• Olsson I L, Breitman T R, Gallo R C. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3′:5′-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Cancer Res 1982; 42: 3928–3933
   PubMed Web of Science ®Google Scholar
• Collins S J, Bodner A, Ting R, et al. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine leukemia cells. Int J Cancer 1980; 25: 213–218
   PubMed Web of Science ®Google Scholar
• Schimke R T. Gene amplification in cultured cells. Cell 1984; 37: 705–713
   PubMed Web of Science ®Google Scholar
• Kartner N, Riordan J R, Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983; 221: 1285–1288
   PubMed Web of Science ®Google Scholar
• Hamada H, Tsuruo T. Functional role for the 170- to 180-kDA glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci (USA) 1986; 83: 7785–7789
   PubMed Web of Science ®Google Scholar
• Muller R, Wagner E F. Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature 1984; 311: 438–442
   PubMed Web of Science ®Google Scholar
• Sager R. Genetic suppression of tumor formation: a new frontier in cancer research. Cancer Res 1986; 46: 1573–1580
   PubMed Web of Science ®Google Scholar
• Marks P A, Sheffery M, Rifkind R A. Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res 1987; 47: 659–666
   PubMed Web of Science ®Google Scholar
• Coppola J J, Cole M D. Constitutive c-myc oncogene expression blocks mouse erythroleukemia ceil differentiation but not commitment. Nature 1986; 320: 760–763
   PubMed Web of Science ®Google Scholar
• Holt J T, Gopal T V, Moulton A D, et al. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci (USA) 1986; 83: 4794–4798
   PubMed Web of Science ®Google Scholar
• Weissman B E, Stanbridge E J. Complementation of the tumorigenic phenotype in human cell hybrids. J Natl Cancer Inst 1983; 70: 667–673
   PubMed Web of Science ®Google Scholar
• Scher B M, Scher W, Robinson A, et al. DNA ligase and DNase activities in mouse erythroleukemia cells during dimethyl suifoxide-induced differentiation. Cancer Res 1982; 42: 1300–1306
   PubMed Web of Science ®Google Scholar
• Greiner J W, Guadagni F, Noguchi P, et al. Use of recombinant interferon to enhance monoclonal antibody-targeting of carcinoma lesions in vivo. Science 1987; 235: 895–898
   PubMed Web of Science ®Google Scholar
• Calvo F, Gauville C, Jabraue P, et al. Effect of recombinant gamma interferon on the expression of estrogen receptors in human breast carcinoma cell lines. First Conference on Differentiation Therapy, Villasimius, Sardinia, 1986; 9
   Google Scholar
• Bloch A. Induced cell differentiation in cancer therapy. Cancer Treat Rep 1984; 68: 199–205
   PubMedGoogle Scholar
• Scott R E, Florine D L, Wille J, et al. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: Grj. Proc Natl Acad Sci (USA) 1982; 79: 845–849
   PubMed Web of Science ®Google Scholar
• Scher W, Scher B M, Waxman S. Proteases act synergistically with low molecular weight inducers to stimulate mouse erythroleukemia cell differentiation. Exp Hematol 1983; 11: 490–498
   PubMed Web of Science ®Google Scholar
• Mickev D D. The effects of differentiation agents on growth characteristics of rat prostate carcinoma. First Conference on Differentiation Therapy, Villasimius, Sardinia, 1986; 60
   Google Scholar